Fda Approved For Pediatric Use - Neonatal Disorders

Relevant Publications

Novel Use of Drug-eluting Stent in Otologic Surgery to Prevent Restenosis.

Issue Release: 2025

Direct oral anticoagulant use in hospitalized pediatric patients: Insights from nationwide data.

Issue Release: 2024

Clinical Evidence Supporting FDA Approval of Gene and RNA Therapies for Rare Inherited Conditions.

Issue Release: 2024

Pediatric Endocrine Society Statement on Considerations for Use of Teplizumab (Tzield™) in Clinical Practice.

Issue Release: 2024

Skeletal overgrowth in a pre-pubescent child treated with pan-FGFR inhibitor.

Issue Release: 2024

Ryzumvi: pioneering advances in countering drug-induced mydriasis.

Issue Release: 2024

Population Pharmacokinetics (PopPK) Support for Pediatric Dosing of Biological Products.

Issue Release: 2024

Hepatic veno-occlusive disease with asparaginase products: a review of cases reported to the FDA adverse event reporting system and published in the literature.

Issue Release: 2024

Food-Drug Effects and Pediatric Drug Development Studies Submitted to the US Food and Drug Administration, 2012-2022.

Issue Release: 2024

Advancing thalamic neuromodulation in epilepsy: Bridging adult data to pediatric care.

Issue Release: 2024

Iwilfin (eflornithine) approved by the FDA as the first and only oral maintenance therapy for high-risk neuroblastoma in adult and pediatric patients: Narrative review.

Issue Release: 2024

Adverse events after chemodenervation with onabotulinum neurotoxin A in children with hypertonia and sialorrhea.

Issue Release: 2024

FDA-Approved Tedizolid Phosphate Prevents Cisplatin-Induced Hearing Loss Without Decreasing Its Anti-tumor Effect.

Issue Release: 2024

Adverse Event Profiles of Adalimumab in Children: A Disproportionality Analysis.

Issue Release: 2024

Candesartan restores blood-brain barrier dysfunction, mitigates aberrant gene expression, and extends lifespan in a knockin mouse model of epileptogenesis.

Issue Release: 2024

Riding the gene therapy wave: challenges and opportunities for rare disease patients and clinicians.

Issue Release: 2024

Exploring the Chronic Nature of Generalized Pustular Psoriasis [Podcast].

Issue Release: 2024

A human-like glutaminase-free asparaginase is highly efficacious in ASNS leukemia and solid cancer mouse xenograft models.

Issue Release: 2024

Optimizing Drug Selection in Children with Multiple Sclerosis: What Do We Know and What Remains Unanswered?

Issue Release: 2024

Triptans in the Acute Migraine Management of Children and Adolescents: An Update.

Issue Release: 2024

What are Food Intolerances?

What Interventions are Available for Managing Abnormal Body Weight?

How is Data Analyzed?

Why is Data Completeness Important in Neonatal Disorders?

What is Decomposition of Pathogens?

Who Sets Pediatric Standards?

What are the Post-Delivery Care Considerations?

What are Advanced Features in Pediatric Care?

How can the need for transfusions be minimized?

How is Acinetobacter baumannii treated in children?

Partnered Content Networks

Relevant Topics